Barely Significant
← all excerpts

Development and Clinical Application of a Real-World Population Pharmacokinetic Model of Rivaroxaban in Asian Patients with Atrial Fibrillation.

Clin Pharmacokinet · 2026 · PMC13272223 · PMID 42143668

2
hedged sentences
0.6400
closest p · 12.8× alpha
0.6400
boldest claim

The sentences

showed a trendP = 0.64not close (p > 0.1)
Conversely, patients with high estimated Ct values showed a trend toward an increased risk of major bleeding, with an incidence of 2.88 per 100 person-years compared with 1.15 in the within-range group (log-rank P = 0.64; HR and 95% CI 2.49 [0.31, 20.18], P = 0.39).

also in 53,322 other papers

a significant trendno p-value reported
This evaluation was conducted to determine whether any of these parameters exhibited a significant trend that would warrant their incorporation into the final PPK model.

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.